improved human relevance of neurobiology: study of ‘omics ... · 1,2 type i diabetes mellitus...

27
Improved Human Relevance of Neurobiology: Study of ‘Omics in Mini - Brains CAAT - Center for Alternatives to Animal Testing Bloomberg School of Public Health, Johns Hopkins University, Baltimore, US Dr. rer. hum. biol. André Kleensang

Upload: others

Post on 22-Jul-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

  • Improved Human Relevance of Neurobiology: Study of ‘Omics in Mini-Brains

    CAAT - Center for Alternatives to Animal TestingBloomberg School of Public Health, Johns Hopkins University, Baltimore, US

    Dr. rer. hum. biol.

    André Kleensang

  • OutlineI. Toxicology in the 21th century – A vision II. Organotypic ModelsIII. Ecosystem Omics & Systems ApproachesIV. If time left: Humans(Organs)-on-a-chip

  • I. Toxicology - $3 billion of testing to regulate $10 trillion of trade

    Problems / Motivation•Throughput•Costs•Animal use•Mixtures•High-dose to low-doseextrapolation

    •Applicability to newproducts/hazards (e.g. nano)

    •Inter individual/speciesdifferences=> Low predictive capacity

    =>Too precautionary

  • 4

    Examples: Reproducibility of animal tests

    • Cancer bioassay: 57% (repeat or mouse vs. rat)• Reproductive Tox: 60% between species• Uterotrophic assay: 26% contradictory• Skin sensitization: 75% guinea pig vs. mouse• Severe eye irritation: 70% reproducible • Acute fish tox: up to 6 log orders different

  • Preclinical tox testing of Aspirin in animals would result in: •R 22 harmful if swallowed •(LD50 = 150-200mg/kg in rats)•R 36 irritant to eyes•R 37 respiratory irritant•R 38 irritant to skin•Not carcinogenic, but co-carcinogen (promotor)•Unclear mutagenicity•Embryonic malformations incat, dog, rat, mice, rabbit, monkey

    => Difficult to be brought tothe market today

    Hartung (2009) ATLA, 37(2), 45 – 47

    Too precautionary…

  • Dependent on use (chemicals, pesticides, drugs,…)and country (EU, USA,…) you may need in addition

    • Repeated dose toxicity• Reproductive and developmental toxicity• Carcinogenicity• Genotoxicity• Immunotoxicity• Skin sensitization• Skin irritation/corrosion• Eye irritation• Phototoxicity• Toxico- and pharmacokinetics• …

    Acute toxicity data is not enough …

  • • Replacement: Don’t use animals if a non-animal method exists that can answer the scientific question at hand.

    • Reduction: If you must use animals, keep the number to the minimum necessary to answer the question.

    • Refinement: If you must use animals, keep any pain or distress they experience to a minimum.

    What are the 3Rs?

    1959 20077

  • => An atmosphere of departure in toxicology

    => New technologies from biotech and (bio)informatics revolution

    NAS vision report Tox-21c

    “We propose a shift from primarily in vivo animal studies to in vitro assays, in vivo assays with lower organisms, and computational modeling for toxicity assessments” F. Collins, NIH, 2008

    “With an advanced field ofregulatory science, new tools, including functional genomics, proteomics, metabolomics, high-throughput screening, andsystems biology, we can

    replace current toxicology assays with tests that incorporate the mechanistic underpinnings of disease and of underlying toxic side effects.” M.A. Hamburg, FDA 2011

  • In vitroIn silico

    (rodent)Animal tests

    Mode of action

    PoT / Toxome

    Deterministic RA(precautionary)

    SystemsToxicology

    ProbabilisticRA

    Evidence-basedTox (EBT)

    ITS &

    validation

    Quality AssuranceTechnology Use

    de facto valid

    Validation

    Evidence-basedTox (EBT)

    http://www.activegarage.com/wordpress/wp-content/uploads/past-future-sign.jpg

  • What we want to measure are the causal events

    What we typically measure

  • PoT ALTEX. 2014;31(1):53-61.

  • II. Organotypic cultures

    Organotypic cultures implies a multi-cellular structurerepresenting at least some of the characteristics and

    functions of the tissue it models

  • Conclusion

    “All models are wrong, but some are useful”

    George EP Box (2005): Statistics for Experimenters (2nd ed.) p 440

    Your scientific question should determine which model to use

  • Limitations and Challenges3D in vitroLower reproducibility

    Endpoints generally need optimization from 2D

    Challenge to study on a single cell level

    Limited perfusion

    2D in vitroLack organ function, structure and complexity

    Cancer or immortalized cells

    Organ-on-chipCostly and complex

    Low availability

    Demands engineering

    skills

    Not suitable for high-throughput screeningOrgan specific biomarkers

  • Organ structure

    Consist of numerous different cell types

    – Many subtypes of neurons– Astrocytes– Oligodendrocytes– Microglia

    Challenges

    • Most complex organ in the human body

    • Blood brain barrier

    • Cerebrospinal fluid in the brain difficult to mimic

    • Different extracellular matrix than commonly found in other organs

    Organ function

    • Sensitive organ to xenobiotic perturbations

    • Action potential

    • Calcium waves in neurons and astrocytes

    • Myelination

    • Cell-cell interactions

    Re-aggregating cultures – Example brain

  • Preparation of rat primary aggregating brain cell cultures

  • Oligodendrocyte/neuron SynapsesAggregate (26 days)

    Astrocyte Myelinated axon20µm 1µm 1µm

    1µm 1µm

    Trapp et al., 1979

    Inner ½ outer ½

    Neur. 32% 13% Astro. 57% 71% Oligo. 9% 3%Others 2% 13%

    1979-2017

    Trapp et al., 1979

  • iPSCs Neural Precursor Cells Gyratory Shaking 3D brain culture

    Human iPSC-derived 3D neural model

    Hogberg et al., (2013) Stem Cell Res Ther. 4(Suppl 1:S4)Pamies et al., (2014), Exp Biol Med 239:1096-107Pamies et al., (2017), Altex 34(3):362-376

  • Re-aggregating cultures – Example brainOrgan function

    Micro-electrode arrays to measure spontaneous electrical activity

    Intracellular calcium response to

    neurotransmitters

    Myelination of axons by oligodendrocytes

    Pamies et al. (2017) ALTEX 34(3):362-376

  • III. Ecosystem: ‘Omics’

    We need as well• (Epi)Genomics

    (Methylation)• Proteomics

    (Phosphorylation)• Metabolomics (flux)• Visualization, interpretation, text mining• Systems/network approaches

    Cave: differential transcriptomics gives only part of the picture!

    To understand

    Andersen et al. (2013) Arch Toxicol 87:7-11

  • Why Systems Toxicology / Network Analysis?

    • Systems approaches offer a dimensionality reduction that is helpful to interpret the data

    • Allows for examining biology as a system rather than at a part-by-part basis

    • Differential/ANOVA/heat map statistics are not adequate to understand a complex system

    • Enrichment (KEGG, BioCyc etc.) and Gene Ontology (GO) depended on using existing annotations/knowledge

  • Group KEGG, WikiPathways, Reactome p-value

  • IV. Human-on-chip• Started as a program for

    countermeasures to bioterrorism• Multi millionaire programs

    – DARPA (Defense Advanced Research Agency), NIH and FDA

    – DTRA (Defense Advanced Research Agency)

    – EU project (Body-on-chip)

    http://en.wikipedia.org/wiki/Organ-on-a-chip

    For more information:http://www.ncats.nih.gov/tissuechip

    http://www.extremetech.com/extreme/167748-us-army-develops-human-on-a-chip-tech-for-chemical-testing-fleshy-robot-soldiers

    http://en.wikipedia.org/wiki/Organ-on-a-chip

    http://en.wikipedia.org/wiki/Organ-on-a-chiphttp://www.ncats.nih.gov/tissuechiphttp://www.extremetech.com/extreme/167748-us-army-develops-human-on-a-chip-tech-for-chemical-testing-fleshy-robot-soldiershttp://en.wikipedia.org/wiki/Organ-on-a-chip

  • 3-tissue-representative organ-on-a-chipsystem

    Skardal et al. (2017) Nature’ Scientific Reports 7:8837

  • Example: two organ-on-a-chip interaction

    Skardal et al. (2017) Nature’ Scientific Reports 7:8837

  • Regulatory acceptance…

  • There is one thing stronger than all the

    armies in the world, and that is an idea whose time

    has come. Victor Hugo

    On résiste à l'invasion des armées;On ne résiste pas à l'invasion des idées.

    The time will come soon to replace current animal toxicology assays with tests that incorporate the mechanistic

    underpinnings of disease and of underlying toxic side effects !

    http://en.wikipedia.org/wiki/File:Agriculture_in_Volgograd_Oblast_002.JPGhttp://www.fotofinder.com/preview/8EA06F4613DBAF78/?usrtrck=searchresult_link_icon_preview&searchresultid=747b1090af0ba3fc2d5b280371bf1593&start=5&text=Metallpresse

    Improved Human Relevance of Neurobiology: Study of ‘Omics in Mini-BrainsOutlineI. Toxicology - $3 billion of testing to regulate $10 trillion of tradeSlide Number 4Slide Number 5Slide Number 6What are the 3Rs?Slide Number 8Slide Number 9Slide Number 10Slide Number 11II. Organotypic culturesConclusionLimitations and ChallengesRe-aggregating cultures – Example brainPreparation of rat primary aggregating brain cell culturesSlide Number 17Slide Number 18Re-aggregating cultures – Example brainSlide Number 20Why Systems Toxicology / Network Analysis?Slide Number 22IV. Human-on-chip3-tissue-representative organ-on-a-chip�systemSlide Number 25Slide Number 26Slide Number 27